STRS Ohio’s Kymera Therapeutics KYMR Stock Holding History

STRS Ohio’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$325K	Hold	3,900	–	–	﹤0.01%	1287
2025 Q4	$303K	Buy	+3,900	New	+$263K	﹤0.01%	1318
2025 Q1	–	Sell	-4,400	Closed	-$177K	–	1977
2024 Q4	$177K	Sell	4,400 -5,200	-54%	-$235K	﹤0.01%	1537
2024 Q3	$454K	Hold	9,600	–	–	﹤0.01%	1306
2024 Q2	$287K	Buy	+9,600	New	+$332K	﹤0.01%	1456
2022 Q3	–	Sell	-11,800	Closed	-$232K	–	2050
2022 Q2	$232K	Sell	11,800 -5,400	-31%	-$126K	﹤0.01%	1562
2022 Q1	$727K	Hold	17,200	–	–	﹤0.01%	1249
2021 Q4	$1.09M	Hold	17,200	–	–	﹤0.01%	1070
2021 Q3	$1.01M	Buy	17,200 +3,000	+21%	+$174K	﹤0.01%	1097
2021 Q2	$688K	Buy	14,200 +5,800	+69%	+$252K	﹤0.01%	1448
2021 Q1	$326K	Buy	8,400 +5,900	+236%	+$355K	﹤0.01%	1693
2020 Q4	$155K	Buy	+2,500	New	+$122K	﹤0.01%	1804

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

STRS Ohio's KYMR Position: Q1 2026 in Review

STRS Ohio held its Kymera Therapeutics (KYMR) position steady in Q1 2026 at 3,900 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

STRS Ohio first reported a position in KYMR in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.09M in Q4 2021. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

STRS Ohio held 3,900 shares of Kymera Therapeutics worth $325K as of Q1 2026.
STRS Ohio left its Kymera Therapeutics share count unchanged in Q1 2026.
Kymera Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1287 holding.
STRS Ohio first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 12 quarters since.
STRS Ohio's Kymera Therapeutics position peaked at $1.09M in Q4 2021.
256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.